Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Ortho Regenerative Technologies Inc. (C:ORTH)

Business Focus: Biotechnology & Medical Research

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

INK Ultra Money Premium

Get a Canadian Insider Club Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • Ad-free browsing
  • INK Ultra Money premium content

(already an Ultra member? Please log into your account for access)

Insider Filings

Latest 10 SEDI filings for ORTH within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Dec 12, 2019 15:30 ET
Ortho RTI Announces Extension of Certain Early Warrants
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES/
Read full article
Oct 15, 2019 20:59 ET
Ortho RTI Announces Extension of Certain Early Warrants
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES/
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
15.02
7.70
Price to Book - most recent quarter
--
2.94
1.98
Price to Cash Flow per share - TTM
--
28.59
11.19
Price to Free Cash Flow per share - TTM
--
1.27
22.36
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Nov 30, 201938,0000
Oct 31, 201923,50019,000
Oct 15, 20194,500-2,000
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Ortho Regenerative Technologies Inc is a Canada-based biotechnology company. The Company is developing a platform for the repair of tears to soft tissues in joints, and for articular cartilage repair, to restore healthy joint motion and prevent or delay osteoarthritis. The Company's initial focus is in creating new treatments for tears to the meniscus in the knee and the shoulder cuff. The Company's biopolymer has been designed for the healing rates of sports related injuries to ligaments, tendons and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention.

See business summary

Twitter

Search (past week) for $ORTH.CA

  • No tweets found

Competitors